Information with respect to this item may be found in Note 12, Legal Proceedings and Contingencies, in our Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, of this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.
In January 2018, our board of directors authorized the use of an additional $30.0 million for the repurchase of our common stock, which was announced on February 1, 2018. In the three months ended March 31, 2018, we purchased approximately 0.5 million shares for approximately $33.3 million. As of March 31, 2018, we had approximately $41.1 million remaining in our repurchase program, which has no expiration date.
All of the shares repurchased were pursuant to our publicly announced repurchase program.
